Korro Bio's total assets for Q3 2024 were $243.54M, a decrease of -2.42% from the previous quarter. KRRO total liabilities were $63.91M for the fiscal quarter, a 24.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.